loperamid viatris 2 mg
viatris limited - loperamidhydroklorid - kapsel, hard - 2 mg
miktosan 0.4 mg
sandoz - københavn - tamsulosinhydroklorid - kapsel med modifisert frisetting, hard - 0.4 mg
tamsulosin viatris 0.4 mg
viatris limited - tamsulosinhydroklorid - kapsel med modifisert frisetting, hard - 0.4 mg
addex-natriumklorid 1 mmol/ ml
fresenius kabi norge as - halden - natriumklorid - konsentrat til infusjonsvæske, oppløsning - 1 mmol/ ml
centyl med kaliumklorid 2.5 mg / 573 mg
karo pharma ab (1) - bendroflumetiazid / kaliumklorid - tablett, filmdrasjert - 2.5 mg / 573 mg
centyl mite med kaliumklorid 1.25 mg / 573 mg
karo pharma ab (1) - bendroflumetiazid / kaliumklorid - tablett, drasjert - 1.25 mg / 573 mg
lisinopril/hydroklortiazid actavis 20 mg / 12.5 mg
actavis group ptc ehf - lisinoprildihydrat / hydroklortiazid - tablett - 20 mg / 12.5 mg
lisinopril/hydroklortiazid actavis 10 mg / 12.5 mg
actavis group ptc ehf - lisinoprildihydrat / hydroklortiazid - tablett - 10 mg / 12.5 mg
sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, type 2 - legemidler som brukes i diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. triple kombinasjon terapi) som et tillegg til diett og trening hos pasienter ikke kontrollert på deres maksimal tolerert dose av metformin og en sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
venlafaxin bluefish 75 mg
bluefish pharmaceuticals ab - venlafaksinhydroklorid - depotkapsel, hard - 75 mg